health 72

Folks in danger for Alzheimer's illness who do extra moderate-intensity bodily exercise, however not light-intensity bodily exercise, usually tend to have wholesome patterns of glucose metabolism of their mind, in response to a brand new UW-Madison examine. Credit score: College of Wisconsin-Madison Folks in danger for Alzheimer's illness who do extra moderate-intensity bodily exercise, however not light-intensity bodily exercise, usually tend to have wholesome patterns of glucose metabolism of their mind, in response to a brand new UW-Madison examine. Outcomes of the analysis have been revealed on-line in  Journal of Alzheimer's Illness . Senior writer Dr. Ozioma Okonkwo, assistant professor of medication, is a researcher on the Wisconsin Alzheimer's Illness Analysis Middle and the Wisconsin Alzheimer's Institute on the UW College of Drugs and Public Well being. First writer Ryan Dougherty is a graduate scholar ...

Recently, safety questions about these medications have been raised in several studies. These studies suggested that PPIs increased the risk for dementia and Alzheimer's disease in people 75-years-old or older. Noting that the prescription of PPIs is on the rise among middle-aged and older adults, a team of researchers designed a new study to examine PPIs and the risk of dementia, mild cognitive impairment, and Alzheimer's disease. They published their study in the  Journal of the American Geriatrics Society . The researchers also examined whether people with mild cognitive impairment who took PPIs were at higher risk for developing dementia or Alzheimer's disease. The researchers examined information from the National Alzheimer's Coordinating Center (NACC) database for 2005 through 2015. Data came from people who were 50-years-old or older and had either normal brain function (their scores on cognitive tests were normal and they could perform everyday activities) o...

"There is good cause for hope that in the next several years much more will be known about how to prevent cognitive decline and dementia, as more clinical trial results become available and more evidence emerges," said Alan I. Leshner, chair of the committee and CEO emeritus, American Association for the Advancement of Science. "Even though clinical trials have not conclusively supported the three interventions discussed in our report, the evidence is strong enough to suggest the public should at least have access to these results to help inform their decisions about how they can invest their time and resources to maintain brain health with aging." An earlier systematic review published in 2010 by the Agency for Healthcare Research and Quality (AHRQ) and an associated "state of the science" conference at the National Institutes of Health had concluded that there was insufficient evidence to make recommendations about any interventions to prevent cogn...